SCHMC

Glu-Ensemble: An ensemble deep learning framework for blood glucose forecasting in type 2 diabetes patients

Metadata Downloads
Abstract
Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels, posing significant health risks such as cardiovascular disease, and nerve, kidney, and eye damage. Effective management of blood glucose is essential for individuals with diabetes to mitigate these risks. This study introduces the Glu-Ensemble, a deep learning framework designed for precise blood glucose forecasting in patients with type 2 diabetes. Unlike other predictive models, Glu-Ensemble addresses challenges related to small sample sizes, data quality issues, reliance on strict statistical assumptions, and the complexity of models. It enhances prediction accuracy and model generalizability by utilizing larger datasets and reduces bias inherent in many predictive models. The framework's unified approach, as opposed to patient-specific models, eliminates the need for initial calibration time, facilitating immediate blood glucose predictions for new patients. The obtained results indicate that Glu-Ensemble surpasses traditional methods in accuracy, as measured by root mean square error, mean absolute error, and error grid analysis. The Glu-Ensemble framework emerges as a promising tool for blood glucose level prediction in type 2 diabetes patients, warranting further investigation in clinical settings for its practical application.
All Author(s)
Yechan Han ; Dae-Yeon Kim ; Jiyoung Woo ; Jaeyun Kim
Issued Date
2024
Type
Article
Keyword
Blood glucose forecastingDeep learningEnsemble methodError grid analysisType 2 diabetes
Publisher
Elsevier
ISSN
2405-8440
Citation Title
Heliyon
Citation Volume
10
Citation Number
8
Citation Start Page
e29030
Citation End Page
e29030
Language(ISO)
eng
DOI
10.1016/j.heliyon.2024.e29030
URI
http://schca-ir.schmc.ac.kr/handle/2022.oak/3424
Appears in Collections:
내분비내과 > 1. Journal Papers
공개 및 라이선스
  • 공개 구분공개
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.